Thrivent Financial for Lutherans’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.4M | Buy |
3,315,425
+1,453,924
| +78% | +$26.5M | 0.13% | 189 |
|
|
2025
Q1 | $36.9M | Buy |
1,861,501
+1,673,881
| +892% | +$33.2M | 0.08% | 297 |
|
|
2024
Q4 | $3.22M | Sell |
187,620
-2,585
| -1% | -$44.3K | 0.01% | 1133 |
|
|
2024
Q3 | $3.8M | Buy |
+190,205
| New | +$3.8M | 0.01% | 1056 |
|
|
2021
Q2 | – | Sell |
-37,525
| Closed | -$66K | – | 2451 |
|
|
2021
Q1 | $66K | Sell |
37,525
-156,225
| -81% | -$275K | ﹤0.01% | 2512 |
|
|
2020
Q4 | $378K | Hold |
193,750
| – | – | ﹤0.01% | 2222 |
|
|
2020
Q3 | $463K | Sell |
193,750
-1,616
| -0.8% | -$3.86K | ﹤0.01% | 2006 |
|
|
2020
Q2 | $573K | Hold |
195,366
| – | – | ﹤0.01% | 1839 |
|
|
2020
Q1 | $563K | Buy |
+195,366
| New | +$563K | ﹤0.01% | 1654 |
|